Aclarion (ACON) shares closed on Friday 110% higher, after the company said it has cancelled an agreement with Ascendiant Capital to offer $10 million shares through a series of at-the-market offerings.
The magnetic resonance spectroscopy company received about $300,000 in gross proceeds through the offerings during the duration of the agreement that was entered in September 2024, according to a regulatory filing on Friday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.